Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-16

FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Camber Pharmaceuticals' Losartan Potassium (generic Losartan Potassium). The approval authorizes changes described i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)